Patents by Inventor Lars Roman Schiemanck

Lars Roman Schiemanck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11607225
    Abstract: Some embodiments of a system or method for treating heart tissue can include a control system and catheter device operated in a manner to intermittently occlude a heart vessel for controlled periods of time that provide redistribution of blood flow. In particular embodiments, the system can be configured to provide an estimation of the cumulative effects of the treatment. For example, some embodiments of the system or method can treat myocardium that is at risk of infarction by intermittently altering blood flow in a venous system to induce microcirculation within the myocardium, and can output a cumulative dosage value indicative of a measurement of progress of reducing an infarct size.
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: March 21, 2023
    Assignee: Miracor Medical SA
    Inventors: Lars Roman Schiemanck, Martin Haidacher
  • Publication number: 20200178974
    Abstract: Some embodiments of a system or method for treating heart tissue can include a control system and catheter device operated in a manner to intermittently occlude a heart vessel for controlled periods of time that provide redistribution of blood flow. In particular embodiments, the system can be configured to provide an estimation of the cumulative effects of the treatment. For example, some embodiments of the system or method can treat myocardium that is at risk of infarction by intermittently altering blood flow in a venous system to induce microcirculation within the myocardium, and can output a cumulative dosage value indicative of a measurement of progress of reducing an infarct size.
    Type: Application
    Filed: February 14, 2020
    Publication date: June 11, 2020
    Inventors: Lars Roman Schiemanck, Martin Haidacher
  • Patent number: 10561425
    Abstract: Some embodiments of a system or method for treating heart tissue can include a control system and catheter device operated in a manner to intermittently occlude a heart vessel for controlled periods of time that provide redistribution of blood flow. In particular embodiments, the system can be configured to provide an estimation of the cumulative effects of the treatment. For example, some embodiments of the system or method can treat myocardium that is at risk of infarction by intermittently altering blood flow in a venous system to induce microcirculation within the myocardium, and can output a cumulative dosage value indicative of a measurement of progress of reducing an infarct size.
    Type: Grant
    Filed: December 29, 2017
    Date of Patent: February 18, 2020
    Assignee: Miracor Medical SA
    Inventors: Lars Roman Schiemanck, Martin Haidacher
  • Publication number: 20180221027
    Abstract: Some embodiments of a system or method for treating heart tissue can include a control system and catheter device operated in a manner to intermittently occlude a heart vessel for controlled periods of time that provide redistribution of blood flow. In particular embodiments, the system can be configured to provide an estimation of the cumulative effects of the treatment. For example, some embodiments of the system or method can treat myocardium that is at risk of infarction by intermittently altering blood flow in a venous system to induce microcirculation within the myocardium, and can output a cumulative dosage value indicative of a measurement of progress of reducing an infarct size.
    Type: Application
    Filed: December 29, 2017
    Publication date: August 9, 2018
    Inventors: Lars Roman Schiemanck, Martin Haidacher
  • Patent number: 9855049
    Abstract: Some embodiments of a system or method for treating heart tissue can include a control system and catheter device operated in a manner to intermittently occlude a heart vessel for controlled periods of time that provide redistribution of blood flow. In particular embodiments, the system can be configured to provide an estimation of the cumulative effects of the treatment. For example, some embodiments of the system or method can treat myocardium that is at risk of infarction by intermittently altering blood flow in a venous system to induce microcirculation within the myocardium, and can output a cumulative dosage value indicative of a measurement of progress of reducing an infarct size.
    Type: Grant
    Filed: December 11, 2013
    Date of Patent: January 2, 2018
    Assignee: Miracor Medical Systems GmbH
    Inventors: Lars Roman Schiemanck, Martin Haidacher
  • Publication number: 20150157326
    Abstract: Some embodiments of a system or method for treating heart tissue can include a control system and catheter device operated in a manner to intermittently occlude a heart vessel for controlled periods of time that provide redistribution of blood flow. In particular embodiments, the system can be configured to provide an estimation of the cumulative effects of the treatment. For example, some embodiments of the system or method can treat myocardium that is at risk of infarction by intermittently altering blood flow in a venous system to induce microcirculation within the myocardium, and can output a cumulative dosage value indicative of a measurement of progress of reducing an infarct size.
    Type: Application
    Filed: December 11, 2013
    Publication date: June 11, 2015
    Inventors: Lars Roman Schiemanck, Martin Haidacher